Our study demonstrates a significant anticancer effect in response to MRT68921, a dual NUAK1/ULK1 inhibitor22,23, and MRT68921 has a strong cytotoxic effect on different cancer cell lines and animal models while sparing normal cells. Here, NUAK1 is linked to cancer.